Atlas Trials

GCC 1366: Anti-Proliferative Response to NeoAdjuvant AIs in Overweight and Obese Patients

Clinical trial NCT02095184 · TERMINATED

Trial details

NCT number
NCT02095184
Sponsor
University of Maryland, Baltimore
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Breast Cancer
Start date
2015-05-25
Primary completion
2024-07-24
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.